Amoy Diagnostics Co Ltd (300685) — Capital Reinvestment Ratio
Amoy Diagnostics Co Ltd (300685) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥110.87 Million) in capital expenditures (CN¥25.34 Million). Check Amoy Diagnostics Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Amoy Diagnostics Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Amoy Diagnostics Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 300685 cash flow conversion.
Annual Capital Reinvestment Ratio for Amoy Diagnostics Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Amoy Diagnostics Co Ltd from 2013 to 2025. See 300685 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥364.82 Million | CN¥70.23 Million | ▲ +63.7% |
| 2024 | 0.12x | CN¥341.85 Million | CN¥40.21 Million | ▼ -21.7% |
| 2023 | 0.15x | CN¥298.72 Million | CN¥44.87 Million | ▼ -71.4% |
| 2022 | 0.53x | CN¥149.04 Million | CN¥78.29 Million | ▲ +18.5% |
| 2021 | 0.44x | CN¥168.16 Million | CN¥74.55 Million | ▲ +69.0% |
| 2020 | 0.26x | CN¥220.69 Million | CN¥57.89 Million | ▲ +70.5% |
| 2019 | 0.15x | CN¥151.52 Million | CN¥23.31 Million | ▼ -63.1% |
| 2018 | 0.42x | CN¥93.45 Million | CN¥38.97 Million | ▲ +76.8% |
| 2017 | 0.24x | CN¥91.89 Million | CN¥21.68 Million | ▼ -83.3% |
| 2016 | 1.42x | CN¥32.18 Million | CN¥45.60 Million | ▼ -9.2% |
| 2015 | 1.56x | CN¥19.10 Million | CN¥29.79 Million | ▼ -47.0% |
| 2014 | 2.94x | CN¥15.69 Million | CN¥46.20 Million | ▼ -25.6% |
| 2013 | 3.96x | CN¥8.56 Million | CN¥33.88 Million | — |